cbdMD (YCBD) Return on Sales (2016 - 2025)

cbdMD has disclosed Return on Sales across 10 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Sales for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q4 2025 at cbdMD, up from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2024 to a low of 0.04% in Q2 2022.
• The 5-year median for Return on Sales is 0.0% (2025), against an average of 0.01%.
• Across the five-year window, Return on Sales slipped 2 bps in 2021 and advanced 3 bps in 2023, its largest moves.
• cbdMD's Return on Sales stood at 0.02% in 2021, then surged by 69 bps to 0.01% in 2022, then surged by 71 bps to 0.0% in 2023, then soared by 102 bps to 0.0% in 2024, then slumped by 2012 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.